ITI News Archive
Stanford Medicine News
-
mRNA vaccine beats infection
Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.
-
Osteoarthritis linked to allergic inflammation
A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.
-
Myc-caused sugar changes protect cancers
A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.
-
Long-COVID clinical trials underway
Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.
-
Cancer cells become cancer cure
Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.
-
One-and-done COVID-19 drug successful
A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.
-
$18 million for transplant and gene-editing research
The California Institute for Regenerative Medicine has funded Stanford Medicine projects to improve kidney transplantation and advance treatment for a rare genetic disease in children.
-
New way to treat COVID-19 smell loss
In a trial led by Stanford Medicine researchers, more than half of patients with persistent smell loss saw improvement with injections of platelet-rich plasma.
-
How COVID-19 virus infects nasal cells
A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.
-
Blood test identifies infections
A diagnostic test developed by Stanford Medicine scientists can separate bacterial and viral infections with 90% accuracy, the first to meet standards set by the World Health Organization.